Our Platform

The small size and unique physical properties of nanoantibodies enable us to treat them like building blocks and generate multivalent, multispecific, and bi-paratopic constructs that can also be linked to payloads or drug conjugates.  

Linking multiple nanoantibodies into a single antibody aggregate with multiple valencies and/or specificities is a simple process and can drastically increase drug efficacy by:

  • Increasing the affinity and stability of the biologic drug

  • Endowing the molecule with a unique target specificity